Compile Data Set for Download or QSAR
Report error Found 110 Enz. Inhib. hit(s) with all data for entry = 12889
LigandPNGBDBM50578160(CHEMBL4878626 | US12291516, Example 109)
Affinity DataIC50: 1.90nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737586(US12291516, Example 99)
Affinity DataIC50: 2.78nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578148(CHEMBL4850186 | US12291516, Example 84)
Affinity DataIC50: 3.46nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578148(CHEMBL4850186 | US12291516, Example 84)
Affinity DataIC50: 3.46nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578148(CHEMBL4850186 | US12291516, Example 84)
Affinity DataIC50: 3.46nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578148(CHEMBL4850186 | US12291516, Example 84)
Affinity DataIC50: 3.46nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578154(CHEMBL4878421 | US12291516, Example 87)
Affinity DataIC50: 4.38nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578159(CHEMBL4863913 | US12291516, Example 91)
Affinity DataIC50: 4.97nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578158(CHEMBL4863836 | US12291516, Example 65)
Affinity DataIC50: 5.06nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578155(CHEMBL4873581 | US12291516, Example 89)
Affinity DataIC50: 6.12nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578167(CHEMBL4874339 | US12291516, Example 85)
Affinity DataIC50: 7.29nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578167(CHEMBL4874339 | US12291516, Example 85)
Affinity DataIC50: 7.29nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578167(CHEMBL4874339 | US12291516, Example 85)
Affinity DataIC50: 7.29nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578167(CHEMBL4874339 | US12291516, Example 85)
Affinity DataIC50: 7.29nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578151(CHEMBL4874550 | US12291516, Example 67)
Affinity DataIC50: 9.12nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737584(US12291516, Example 97)
Affinity DataIC50: 9.22nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578135(CHEMBL4856243 | US12291516, Example 73)
Affinity DataIC50: 9.68nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737587(US12291516, Example 100)
Affinity DataIC50: 9.99nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578152(CHEMBL4860527 | US12291516, Example 72)
Affinity DataIC50: 10.1nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578161(CHEMBL4852838 | US12291516, Example 111)
Affinity DataIC50: 10.6nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578172(CHEMBL4855886 | US12291516, Example 90)
Affinity DataIC50: 10.7nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578172(CHEMBL4855886 | US12291516, Example 90)
Affinity DataIC50: 10.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578172(CHEMBL4855886 | US12291516, Example 90)
Affinity DataIC50: 10.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578172(CHEMBL4855886 | US12291516, Example 90)
Affinity DataIC50: 10.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737569((S)-2-(1-acryloylpiperidin-2-yl)-4-(4-((4-ethylpyr...)
Affinity DataIC50: 11nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578152(CHEMBL4860527 | US12291516, Example 72)
Affinity DataIC50: 11.2nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737534(US12291516, Example 26)
Affinity DataIC50: 12.5nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578134(CHEMBL4871950 | US12291516, Example 46)
Affinity DataIC50: 13.1nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737537(US12291516, Example 33)
Affinity DataIC50: 13.5nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737580(US12291516, Example 93)
Affinity DataIC50: 14.6nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578178(CHEMBL4847824 | US12291516, Example 110)
Affinity DataIC50: 14.8nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737593(US12291516, Example 106)
Affinity DataIC50: 15nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578176(CHEMBL4849268 | US12291516, Example 66)
Affinity DataIC50: 16.4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578146(CHEMBL4868899 | US12291516, Example 77)
Affinity DataIC50: 17.9nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578148(CHEMBL4850186 | US12291516, Example 84)
Affinity DataIC50: 18.1nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578149(CHEMBL4846437 | US12291516, Example 61)
Affinity DataIC50: 18.4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737534(US12291516, Example 26)
Affinity DataIC50: 18.4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578165(CHEMBL4855655 | US12291516, Example 105)
Affinity DataIC50: 18.7nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM737583(US12291516, Example 96)
Affinity DataIC50: 19.2nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578170(CHEMBL4852748 | US12291516, Example 98)
Affinity DataIC50: 19.4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578170(CHEMBL4852748 | US12291516, Example 98)
Affinity DataIC50: 19.4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578170(CHEMBL4852748 | US12291516, Example 98)
Affinity DataIC50: 19.4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578170(CHEMBL4852748 | US12291516, Example 98)
Affinity DataIC50: 19.4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578171(CHEMBL4854853 | US12291516, Example 88)
Affinity DataIC50: 22.6nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578150(CHEMBL4878506 | US12291516, Example 71)
Affinity DataIC50: 22.6nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

LigandPNGBDBM50578179(CHEMBL4861285 | US12291516, Example 112)
Affinity DataIC50: 22.8nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Displayed 1 to 50 (of 110 total ) | Next | Last >>
Jump to: